y HemaCare Corp., of Los Angeles, completed a $1 million privateplacement of 250,000 units (at $4 per unit), composed of 250,000shares of common stock and warrants to purchase an additional750,000 shares at intervals over the next two years. Torrey PinesSecurities Inc., of Sonoma Beach, Calif., acted as finder for thetransaction. Proceeds will be used to fund Immupath, a potentialtreatment for AIDS, and for the company's new stem-cell collectionand cryopreservation projects.y GenPharm International Inc. said Tuesday that its operation inLeiden, The Netherlands, signed a research agreement with LeidenUniversity to develop transgenic animals capable of producing highlevels of Immunoglobulin A in their milk.y Matrix Pharmaceutical Inc., of Menlo Park, Calif., reported datayesterday that provides first evidence that it's implant products(IntraDose-FU, Intradose-CDDP and MPI 5015) may be effective forpancreatic cancer therapy. The in vivo and in vitro studies revealed thatthere is a significant increase in response to chemotherapeutic agentswhen administered as therapeutic implants by an intratumoral injectionover intraperitoneal injection or intratumoral injection of free drug.

(c) 1997 American Health Consultants. All rights reserved.